Transcranial Magnetic Stimulation
95
21
25
38
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.1%
2 terminated out of 95 trials
95.0%
+8.5% vs benchmark
1%
1 trials in Phase 3/4
13%
5 of 38 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 38 completed trials
Clinical Trials (95)
rTMS for Postoperative Brain Tumor Patients
Effects of the Stimulation Site of tsMS With TMS on Functional Mobility in Individuals With Parkinson's Disease
Transcranial Magnetic Stimulation on Somtosensory Cortex Enhances Motor Learning in People With Stroke
Pilot Study of Neuromodulation for Enhancement of Emotion Regulation in Bipolar Mood Disorders
iTBS/fMRI Study of Hierarchical Control in the PFC
Theta Burst Stimulation in the Management of Methamphetamine Use Disorder in Indonesia
iTBS/fMRI Study of Apex Control
Reward Circuit Targeted iTBS
Varenicline and Accelerated Transcranial Magnetic Stimulation (TMS) for Quitting Nicotine Use (Pilot Study)
Personalized iTBS in Real-World Clinical Settings for Schizophrenia
Examining the Effectiveness of Deep TMS in Veterans With Alcohol Use Disorder
Comparison of the Efficacy of Accelerated Intermittent Theta Burst Stimulation and Accelerated Continuous Theta Burst Stimulation in Patients With Treatment-Resistant Depression
Transcranial Magnetic Stimulation for Apathy in Mild Cognitive Impairment
Advantage of Cerebellar Transcranial Magnetic Stimulation in Alzheimer's Diseases （ACT-AD）
Effect of rTMS of the Cerebellum on Parkinson's Disease
Dual-target, High-dose TMS for PD Patients With FOG
Effect of Theta-Burst Transcranial Magnetic Stimulation (TBS) for Freezing of Gait
Brain Stimulation for Concussion
Safty and Efficacy of MCI Network Guided TMS for Early Alzheimer's Disease: A Randomized, Double-blind Trial
Deep TMS of Neural Circuits Associated With Stimulant Use Disorder